Mahboubeh Ebrahimian
- Pharmaceutical Science top 5%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 5
-
- Immunotherapy and Immune Responses 3
-
- RNA Interference and Gene Delivery 12
- Advanced biosensing and bioanalysis techniques 4
- Extracellular vesicles in disease 2
-
- Saffron Plant Research Studies 3
-
- Medicinal plant effects and applications 2
-
- Soil and Environmental Studies 2
- Co-authors
- Maryam HashemiMohammad RamezaniAlireza HaghparastKhalil AbnousMohsen MalekiZahra SalmasiAhad MokhtarzadehFatemeh Oroojalian
- Journals
- SHILAP Revista de lepidopterología (6 papers)Frontiers in Immunology (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- IranUnited StatesItaly
In The Last Decade
Mahboubeh Ebrahimian
19 papers receiving 329 citations
Peers
Comparison fields: 5 of 69
- Pharmaceutical Science 63
- Biomaterials 96
- Immunology 71
- Molecular Biology 192
- Molecular Medicine 13
Countries citing papers authored by Mahboubeh Ebrahimian
This map shows the geographic impact of Mahboubeh Ebrahimian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahboubeh Ebrahimian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahboubeh Ebrahimian more than expected).
Fields of papers citing papers by Mahboubeh Ebrahimian
This network shows the impact of papers produced by Mahboubeh Ebrahimian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahboubeh Ebrahimian. The network helps show where Mahboubeh Ebrahimian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mahboubeh Ebrahimian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2022 | 22 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 17 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 29 | |
| 8 | 2018 | 15 | |
| 9 | 2018 | 27 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 44 | |
| 12 | 2017 | 35 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 10 | |
| 15 | 2016 | 19 | |
| 16 | 2016 | 27 | |
| 17 | 2016 | 25 | |
| 18 | 2016 | 9 | |
| 19 | 2010 | 6 |
About Mahboubeh Ebrahimian
Mahboubeh Ebrahimian is a scholar working on Complementary and alternative medicine, Biomaterials and Pharmaceutical Science, having authored 19 papers that have together received 333 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (12 papers), Nanoparticle-Based Drug Delivery (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Saffron Plant Research Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Extracellular vesicles in disease (2 papers), Medicinal plant effects and applications (2 papers) and Soil and Environmental Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (63 citations), Biomaterials (96 citations) and Immunology (71 citations). Mahboubeh Ebrahimian has collaborated with scholars based in Iran, United States and Italy. Frequent co-authors include Maryam Hashemi, Mohammad Ramezani, Alireza Haghparast, Khalil Abnous, Mohsen Maleki, Zahra Salmasi, Ahad Mokhtarzadeh, Fatemeh Oroojalian, Bizhan Malaekeh‐Nikouei and Sahar Taghavi. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.